Accelerate Diagnostics Inc ROCE
Was ist das ROCE von Accelerate Diagnostics Inc?
ROCE von Accelerate Diagnostics Inc ist -294.47%
Was ist die Definition von ROCE?
Die Kapitalerträge (ROCE) entsprechen einer Finanzkennzahl, die die Rentabilität eines Unternehmens und die Effizienz, mit der sein Kapital verwendet wird, misst.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Accelerate Diagnostics Inc
Was macht Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Unternehmen mit roce ähnlich Accelerate Diagnostics Inc
- Anchiano Therapeutics Ltd hat ROCE von -305.12%
- GetBack S.A hat ROCE von -300.03%
- Phunware Inc hat ROCE von -299.88%
- Avidian Gold hat ROCE von -299.09%
- Sonnet BioTherapeutics Inc hat ROCE von -297.19%
- Aziyo Biologics hat ROCE von -295.71%
- Accelerate Diagnostics Inc hat ROCE von -294.47%
- Exicure hat ROCE von -292.22%
- Exicure hat ROCE von -292.22%
- Exicure hat ROCE von -292.22%
- Exicure hat ROCE von -292.22%
- Portage Biotech hat ROCE von -287.54%
- Adial Pharmaceuticals hat ROCE von -286.20%